New York State Common Retirement Fund
AMRI

New York State Common Retirement Fund’s Albany Molecular Research Inc AMRI Stock Holding History

New York State Common Retirement Fund’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-26,000
Closed -$564K – 3177
2017
Q2 		$564K Sell
26,000
-83,752
-76% -$1.52M ﹤0.01% 2352
2017
Q1 		$1.54M Buy
109,752
+85,352
+350% +$1.4M ﹤0.01% 1811
2016
Q4 		$458K Hold
24,400
– – ﹤0.01% 2406
2016
Q3 		$403K Hold
24,400
– – ﹤0.01% 2421
2016
Q2 		$328K Hold
24,400
– – ﹤0.01% 2479
2016
Q1 		$373K Sell
24,400
-45,050
-65% -$706K ﹤0.01% 2375
2015
Q4 		$1.38M Hold
69,450
– – ﹤0.01% 1797
2015
Q3 		$1.21M Sell
69,450
-23,574
-25% -$480K ﹤0.01% 1840
2015
Q2 		$1.88M Buy
93,024
+19,843
+27% +$383K ﹤0.01% 1884
2015
Q1 		$1.29M Buy
73,181
+30,281
+71% +$516K ﹤0.01% 1792
2014
Q4 		$698K Buy
42,900
+6,100
+17% +$112K ﹤0.01% 1908
2014
Q3 		$812K Buy
36,800
+3,800
+12% +$77.8K ﹤0.01% 1908
2014
Q2 		$664K Buy
+33,000
New +$559K ﹤0.01% 1932
2013
Q3 		– Sell
-201,425
Closed -$2.39M – 1986
2013
Q2 		$2.39M Buy
+201,425
New +$2.18M ﹤0.01% 1372

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

New York State Common Retirement Fund's AMRI Position: Q3 2017 in Review

New York State Common Retirement Fund sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 26,000 shares — an estimated $564K sold.

New York State Common Retirement Fund first reported a position in AMRI in Q2 2013 and held it in 14 quarters. The position peaked at $2.39M in Q2 2013. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • New York State Common Retirement Fund reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • New York State Common Retirement Fund sold 26,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $564K.
  • New York State Common Retirement Fund first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 14 quarters.
  • New York State Common Retirement Fund's Albany Molecular Research Inc position peaked at $2.39M in Q2 2013.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on New York State Common Retirement Fund's 13F filing for Q3 2017, filed 6 Nov 2017.